［1］Bosisio M，Caraceni A，Grassi L.Phenomenology of delirium in cancer patients，as described by the memorial delirium assessment scale(MDAS)a nd the delirium rating scale(DRS)［J］.Psychosomatics，2006，47(6)：471-478.
［2］LIAO JM，WANG XL.The current research situation of the assessment tools of delirium［J］.Chinese Journal of Multiple Organ Diseases in the Elderly，2012，11(11)：878-880.［廖金敏，王希林.谵妄评估工具的研究现状［J］.中华老年多器官疾病杂志，2012，11(11)：878-880.］
［3］Hempenius L，Slaets JP，Van AD，et al.Outcomes of a geriatric liaison Intervention to prevent the development of postoperative delirium in frail elderly cancer patients：Report on a multicentre，randomized，controlled trial［J］.Plos One，2013，8(6)：e64834.
［4］Bathula M，Gonzales JP.The pharmacologic treatment of intensive care unit delirium：a systematic review［J］.Annals of Pharmacotherapy，2013，47(9)：1168-1174.
［5］LIU B，LI MY，JIN Y.Clinical analysis and discussion of senile delirium［J］.Modern Journal of Integrated Traditional Chinese and Western Medicine，2012，21(30)：3361-3362.［刘波，李明阳，靳英.老年期谵妄临床分析与探讨［J］.现代中西医结合杂志，2012，21(30)：3361-3362.］
［6］WANG YY，LIAO YM，YUE JR.Research on the mechanism of delirium based on related serum biomarkers of the delirium［J］.Journal of Biomedical Engineering，2017，34(3)：465-470.［王艳艳，廖玉麟，岳冀蓉.从谵妄的血清生物标志物探讨谵妄发生机制［J］.生物医学工程学杂志，2017，34(3)：465-470.］
［7］Swarm RA，Maria D.NCCN Frameworks for resource stratification of NCCN guidelines：adult cancer pain and palliative care［J］.Journal of the National Comprehensive Cancer Network，2018，16(5S)：628-631.
［8］Levy MH，Back A，Benedetti C，et al.NCCN clinical practice guidelines in oncology：palliative care［J］.J Natl Compr Canc Netw，2009，7(4)：436-473.
［9］PANG Y，TANG LL.Principles of diagnosis and treatment for delirium in cancer patients［J］.Chinese Journal of Pain Medicine，2012，18(10)：586-589.［庞英，唐丽丽.肿瘤患者谵妄的诊治原则［J］.中国疼痛医学杂志，2012，18(10)：586-589.］
［10］LI XH，CHEN HY，LIU M，et al.Management of delirium in patients with advanced cancer［J］.Chinese Journal of Clinical Oncology and Rehabilitation，2016，2016(9)：1145-1147.［李先华，陈怀英，刘媚，等.晚期肿瘤患者谵妄症状的观察和处理［J］.中国肿瘤临床与康复，2016，2016(9)：1145-1147.］
［11］Pelland C，Trudel JF.Atypical antipsychotic efficacy and safety in managing delirium：A systematic review and critical analysis［J］.Psychol Neuropsychiatr Vieil，2009，7(2)：109-119.
［12］Fong TG，Tulebaev SR，Inouye SK.Delirium in elderly adults：Diagnosis，prevention and treatment［J］.Nature Reviews Neurology，2009，5(4)：210-220.
［13］LI J.Preliminary evaluation of the efficacy and safety of olanzapine in the treatment of acute phase psychotherapy［J］.Guide of China Medicine，2018，2018(3)：102-103.［李静.急性期精神病治疗中奥氮平的应用效果及安全性初步评价［J］.中国医药指南，2018，2018(3)：102-103.］
［14］Roth AJ，Modi R.Psychiatric issues in older cancer patients［J］.Critical Reviews in Oncology/Hematology，2003，48(2)：185-197.
［15］Jain R，Arun P，Sidana A，et al.Comparison of efficacy of haloperidol and olanzapine in the treatment of delirium［J］.Indian Journal of Psychiatry，2017，59(4)：451-456.
［16］Passik SD，Cooper M.Complicated delirium in a cancer patient successfully treated with olanzapine［J］.J Pain Symptom Manage，1999，17(3)：219-223.
［17］Seymour CW，Pandharipande PP，Koestner T，et al.Diurnal sedative changes during intensive care：impact on liberation from mechanical ventilation and delirium［J］.Critical Care Medicine，2012，40(10)：2788.
［18］WU LX，DU XG，ZHAO LM.Observation of the effect of dexmedetomidine on total hip arthroplasty in elderly patients［J］.China Health Care & Nutrition，2015，25(16)：197-198.［吴丽霞，都兴光，赵立明.右美托咪定用于老年患者全髋关节置换术的麻醉效果观察［J］.中国保健营养，2015，25(16)：197-198.］
［19］WANG HY，JI JH，WANG XM.Advances of the research of dexmedetomidlne in trauflc brain injury［J］.International Journal of Anesthesiology and Resuscitation，2012，33(8)：569-573.［王海燕，季君慧，王学敏.右旋美托咪啶在创伤性脑损伤中应用的研究进展［J］.国际麻醉学与复苏杂志，2012，33(8)：569-573.］
［20］Brune S，Schepmann D，Klempnauer KH，et al.The sigma enigma：In vitro/in silico site-directed mutagenesis studies unveil receptor ligand binding［J］.Biochemistry，2014，53(18)：2993-3003.
［21］Pandharipande PP，Sanders RD，Girard TD，et al.Correction：Effect of dexmedetomidine versus lorazepam on outcome in patientswith sepsis：an a priori-designed analysis of the MENDS randomizedcontrolled trial［J］.Critical Care，2010，14(2)：R38.
［22］Hyun LS，Namo K，Yeong LC，et al.Effects of dexmedetomidine on oxygenation and lung mechanics in patients with moderate chronic obstructive pulmonary disease undergoing lung cancer surgery：A randomised double-blinded trial［J］.European Journal of Anaesthesiology，2016，33(4)：275-282.
［23］ZHANG JR，DONG N，QIAN HD，et al.Dexmedetomidine improves function of lung oxygenation in patients with moderate chronic obstructive pulmonary disease underwent lung cancer surgery［J］.Journal of Central South University(Medical Sciences)，2017，42(3)：271-276.［张继如，董楠，钱红娣，等.右美托咪定改善合并中度慢性阻塞性肺疾病肺癌手术患者的肺氧合功能［J］.中南大学学报(医学版)，2017，42(3)：271-276.］